Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130711 (US8822448, 23) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet  | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130738 (US8822448, 129) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130781 (US8822448, 211) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130780 (US8822448, 210) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130729 (US8822448, 94) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130779 (US8822448, 208) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130778 (US8822448, 207) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130794 (US8822448, 648) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130709 (US8822448, 17) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130710 (US8822448, 22) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130782 (US8822448, 212) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130751 (US8822448, 169) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130776 (US8822448, 203) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130740 (US8822448, 139) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130771 (US8822448, 198) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130793 (US8822448, 640) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130726 (US8822448, 86) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130759 (US8822448, 183) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130775 (US8822448, 202) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130762 (US8822448, 186) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.80 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130717 (US8822448, 53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130715 (US8822448, 49) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130721 (US8822448, 66) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130750 (US8822448, 168) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130785 (US8822448, 217) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130755 (US8822448, 178) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130757 (US8822448, 181) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130770 (US8822448, 195) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130719 (US8822448, 56) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130772 (US8822448, 199) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130760 (US8822448, 184) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130795 (US8822448, 655) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 4.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130736 (US8822448, 127) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130743 (US8822448, 148) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130737 (US8822448, 128) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130742 (US8822448, 146) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130758 (US8822448, 182) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130714 (US8822448, 41) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130769 (US8822448, 193) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130733 (US8822448, 109) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.80 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130790 (US8822448, 283) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130728 (US8822448, 92) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130777 (US8822448, 204) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130752 (US8822448, 173) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130774 (US8822448, 201) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130756 (US8822448, 179) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130765 (US8822448, 189) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130748 (US8822448, 162) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130716 (US8822448, 50) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130766 (US8822448, 190) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130704 (US8822448, 6) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.60 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130744 (US8822448, 150) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130739 (US8822448, 133) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130741 (US8822448, 145) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130720 (US8822448, 63) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130763 (US8822448, 187) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130753 (US8822448, 176) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130705 (US8822448, 12) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.60 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130734 (US8822448, 119) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130713 (US8822448, 40) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130773 (US8822448, 200) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130708 (US8822448, 16) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130712 (US8822448, 28) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130725 (US8822448, 84) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130767 (US8822448, 191) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.5 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130754 (US8822448, 177) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.70 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130797 (US8822448, 668) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.80 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130792 (US8822448, 624) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130749 (US8822448, 166) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130783 (US8822448, 213) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130768 (US8822448, 192) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 11 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130723 (US8822448, 74) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130727 (US8822448, 87) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130703 (US8822448, 2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 12 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130731 (US8822448, 103) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 13 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130730 (US8822448, 95) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130764 (US8822448, 188) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 14 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130787 (US8822448, 219) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130732 (US8822448, 107) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130718 (US8822448, 55) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 15 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130784 (US8822448, 214) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130788 (US8822448, 220) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 16 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130722 (US8822448, 70) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130786 (US8822448, 218) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 17 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130702 (US8822448, 1) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130735 (US8822448, 123) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 18 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130761 (US8822448, 185) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 19 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130791 (US8822448, 427) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 20 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130724 (US8822448, 79) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 23 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130789 (US8822448, 221) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 24 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130796 (US8822448, 660) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 28 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM8366 (CHEMBL1809169 | US8822448, 147 | US9771375, Exampl...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 30 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130747 (US8822448, 161) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 31 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130746 (US8822448, 154) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 32 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM8368 (CHEMBL1809167 | US8822447, 106 | US8822448, 179 | ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM8526 (CHEMBL1809170 | US8822447, 107 | US8822448, 184 | ...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 40 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130745 (US8822448, 152) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 53 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130707 (US8822448, 14) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 81 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM130706 (US8822448, 13) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 85 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (Rattus norvegicus (Rat)) | BDBM8367 (US8822448, 174) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | 8.0 | n/a |
Astellas Pharma Inc. US Patent | Assay Description The PDE9-inhibiting activity was measured by the following method. That is, to a buffer solution containing tris(hydroxymethyl)aminomethane-hydrochlo... | US Patent US8822448 (2014) BindingDB Entry DOI: 10.7270/Q2BK1B1J | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
